Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing - R3

This coverage article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: July 31, 2020
Summary of Article Changes:
Addition of coding to Group 1:
C54.1 - Malignant neoplasm of endometrium
Z15.04 - Genetic susceptibility to malignant neoplasm of endometrium

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.


            Last Updated Thu, 09 Jul 2020 17:33:07 +0000